U.S. COMPANY FILING
Edwards Lifesciences Corp — Form 10-Q filed 2026-08-04
Filing text preview
Edwards Lifesciences reported Q2 2026 net sales of $1,741.0 million, up 13.6% year-over-year, and H1 net sales of $3,389.6 million, up 15.1%. The company completed the acquisition of Autus and consolidated a VIE, recognizing gains and impairments. It also faces tax disputes with the IRS and Israel Tax Authority, and multiple lawsuits.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record